99mTc-DTPA uptake and electrical impedance measurements in verification of in vivo electropermeabilization efficiency in rat muscle

Cancer Biotherapy and Radiopharmaceuticals

Volumn 21, Issue 6, 2006, Pages 623-635

  Grafström, Gustav ^a   Engström, Per ^a   Salford, Leif G ^a   Persson, Bertil R R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

99mTC DTPA; Admittance; Cell membranes; Chemotherapy; Clinical dosimetry; DNA plasmid transfection; Electrical impedance; Electropermeabilization; Electroporation; Gamma camera; Gene therapy; In vivo transfection; RNAi (RNA interference); Vaccination

Indexed keywords

PENTETATE TECHNETIUM TC 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DNA TRANSFECTION; DRUG UPTAKE; ELECTRIC FIELD; ELECTRIC POTENTIAL; ELECTROPORATION; FEMALE; GENE THERAPY; IMMUNIZATION; IMPEDANCE; IN VIVO STUDY; MALE; MEASUREMENT; MUSCLE TISSUE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; RNA INTERFERENCE; SCINTILLATION CAMERA; SKELETAL MUSCLE; VACCINATION; ANIMAL; DRUG EFFECT; ELECTRON; MUSCLE; TIME;

ANIMALS; ELECTRIC IMPEDANCE; ELECTRONS; ELECTROPORATION; FEMALE; MALE; MUSCLES; RATS; TECHNETIUM TC 99M PENTETATE; TIME FACTORS;

EID: 33846611466     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2006.21.623     Document Type: Article

References (63)

1. Stampfli R. Reversible electrical breakdown of the excitable membrane of a Ranvier node. Ann Acad Bras Cien 1958;30:57.
2. Zimmermann U, Pilwat G, Riemann F. Dielectric break-down of cell membranes. Biophys J 1974;14:881.
3. Zimmermann U, Neil GA. Electromanipulation of Cells. CRC Press, Inc., Boca Raton, FL, 1996.
4. Neumann E, Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J Memb Biol 1972;10:279.
5. Neumann E, Schaeferridder M, Wang Y, et al. Gene transfer into mouse lyoma cells by electropermeabilization in high electric fields. EMBO J 1982;1:841.
6. Neumann E, Sprafke A, Boldt E, et al. Biophysical considerations of membrane electropermeabilization. In: Chang DC, Chassy BM, Saunders JA, Sowers AE, eds., Guide to Electropermeabilization and Electrofusion. Academic Press, San Diego, CA.
7. Persson BRR. Applications and control of high-voltage pulse delivery for tumor therapy and gene therapy. In: Lin JC, Advances in Electromagnetic Fields in Living Systems. New York: Kluwer Academic/Plenum Publishers, 2000:121.
8. Okino M, Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jap J Cancer Res 1987;78:1319.
9. Belehradek J, Orlowski S, Poddevin B, et al. Electrochemotherapy of spontaneous mammary tumors in mice. Eur J Cancer 1991;27:73.
10. Salford LG, Persson RBR, Brun A, et al. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 1993;194:938.
11. Jaroszeski MJ, Gilbert RA, Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1997;1334:15.
12. Jaroszeski MJ, Illingworth P, Pottinger C, et al. Electrically mediated drug delivery for treating subcutaneous and orthotopic pancreatic adenocarcinoma in a hamster model. Anticancer Res 1999;19:989.
13. Hasegawa H, Kano M, Hoshi N, et al. An electrochemotherapy model for rat tongue carcinoma. J Oral Pathol Med 1998;27:249.
14. Chazal M, Benchimol D, Baque P, et al. Treatment of hepatic metastases of colorectal cancer by electrochemotherapy: An experimental study in the rat. Surgery 1998;124:536.
15. Hyacinthe M, Jaroszeski MJ, Dang VV, et al. Electrically enhanced drug delivery for the treatment of soft-tissue sarcoma. Cancer 1999;85:409.
16. Kuriyama S, Kikukawa M, Mitoro A, et al. Antitumor effect of electrochemotherapy on colorectal carcinoma in an orthotopic mouse model. Int J Oncol 1999;14:321.
17. 111In-bleomycin complex in normal and glioma bearing rats after in vivo electropermeabilization using exponential high-voltage pulses. Bioelectrochem Bioenerget 1998;46:241.
18. Belehradek M, Domenge C, Luboinski B, et al. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993;72:3694.
19. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996;77:964.
20. Heller R, Jaroszeski MJ, Reinigen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148.
21. Sersa G, Stabuc B; Cemazar M, et al. Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer 1998;34:1213.
22. Mir LM, Glass LF, Sersa G, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998;77:2336.
23. Daskalov I, Mudrov N, Peycheva E. Exploring new instrumentation parameters for electrochemotherapy. Attacking tumors with bursts of biphasic pulses instead of single pulses. IEEE Eng Med Biol Mag 1999;18:62.
24. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electropermeabilization. Cancer Treat Rev 2003;29:371.
25. Bunan M, Formanek M, Regele H. Electropermeabilization therapy in head and neck cancer. Acta Otolaryngol 2003;123:264.
26. Cemazar M, Miklavcic D, Mir LM, et al. Electrochemotherapy of tumours resistant to cisplatin: A study in a murine tumour model. Eur J Cancer 2001; 37:1166.
27. Sersa G, Stabuc B, Cemazar M, et al. Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6:863.
28. Sersa G, Stabuc B, Cemazar M, et al. Electrochemotherapy with cisplatin: The systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res 2000;10:381.
29. Rebersek M, Cufer T, Cemazar M, et al. Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer. Anticancer Drugs 2004;15:593.
30. Nishi T, Yoshizato K, Yamashiro S, et al. High-efficiency in vivo gene transfer using intra-arterial plasmid DNA injection following in vivo electropermeabilization. Cancer Res 1996;56:1050.
31. Heller R, Jaroszeski M, Atkin A, et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996;389:225.
32. Oshima Y, Sakamoto T, Yamanaka I, et al. Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther 1998;5:1347.
33. Aihara H, Miyazaki J. Gene transfer into muscle by electropermeabilization in vivo. Nat Biotechnol 1998; 16:867.
34. Suzuki T, Shin BC, Fujikura K, et al. Direct gene transfer into rat liver cells by in vivo electropermeabilization. FEBS Lett 1998;425:436.
35. Rols MP, Delteil C, Golzio M, et al. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998;16:168.
36. Mir LM, Bureau MF, Rangara R, et al. Long-term, high-level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998;321:893.
37. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999;6:508.
38. Andre F, Mir LM. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 2004;11:833.
39. Maruyama H, Miyazaki J, Gejyo F. Epidermis-targeted gene transfer using in vivo electropermeabilization. Meth Mol Biol 2005;289:431.
40. Golzio M, Rols MP, Teissie J. In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expression. Methods 2004;33:126.
41. Golzio M, Mazzolini L, Moller P, et al. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Ther 2005;12:246.
42. Saeboe-Larssen S, Fossberg E, Gaudernack G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T-lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Meth 2002;259:191.
43. Kyte JA, Kvalheim G, Aamdal S, et al. Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination. Cancer Gene Ther 2005;12:579.
44. Rizzuto G, Cappelletti M, Maione D, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electropermeabilization. Proc Natl Acad Sci USA 1999;96:6417.
45. Tollefsen S, Tjelle TE, Schneider J, et al. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electropermeabilization. Vaccine 2002;20:3370.
46. Tollefsen S, Vordermeier M, Olsen I, et al. DNA injection in combination with electropermeabilization: A novel method for vaccination of farmed ruminants. Scand J Immunol 2003;57:229.
47. Scheerlinck JPY, Karlis J, Tjelle TE, et al. In vivo electropermeabilization improves immune responses to DNA vaccination in sheep. Vaccine 2004;22:1820.
48. Luxembourg A, Hannaman D, Masterson S, et al. Potentiation of DNA vaccination using an integrated application system for electropermeabilization- mediated intramuscular delivery. Mol Ther 2005;11:S215.
49. Luxembourg A, Hannaman D, Ellefsen B, et al. Enhancement of immune responses to an HBV DNA vaccine by electropermeabilization. Vaccine 2006;24:4690.
50. Tjelle TE, Corthay A, Lunde E, et al. Monoclonal antibodies produced by muscle after plasmid injection and electropermeabilization. Mol Ther 2004;9:328.
51. Babiuk S, Baca-Estrada ME, Foldvari M, et al. Electropermeabilization improves the efficacy of DNA vaccines in large animals. Vaccine 2002;20:3399.
52. Babiuk S, Baca-Estrada ME, Foldvari M, et al. Increased gene expression and inflammatory cell infiltration caused by electropermeabilization are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004;110:1.
53. Gronevik E, Tollefsen S, Sikkeland LIB, et al. DNA transfection of mononuclear cells in muscle tissue. J Gene Med 2003;5:909.
54. Gronevik E, Mathiesen I, Lomo T. Early events of electropermeabilization- mediated intramuscular DNA vaccination potentiate Thi-directed immune responses. J Gene Med 2005;7:1246.
55. Gronevik E, von Steyern FV, Kalhovde JM, et al. Gene expression and immune response kinetics using electropermeabilization-mediated DNA delivery to muscle. J Gene Med 2005;7:218.
56. Buchan S, Grønevik E, Mathiesen I, et al. Electropermeabilization as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen1. J Immunol 2005;174:6292.
57. Webster JG. Electrical Impedance Tomography. Bristol, United Kingdom: Adam Hilger, 1999.
58. Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electropermeabilization, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999;261:377.
59. Gehl J, Sorensen TH, Nielsen K, et al. In vivo electropermeabilization of skeletal muscle: Threshold, efficacy, and relation to electric field distribution. Biochim Biophys Acta 1999;1428:233.
60. Grimnes S, Martinsen OG. Bioimpedance and Bioelectricity Basics. London: Academic Press, 2000.
61. Wheldon TE. Models of tumour growth. Mathematical models in cancer research. TJI: Mould RF, Medical Science Series. Bristol, United Kingdom: Adam Hilger, 1988:63.
62. Satkauskas S, Bureau MF, Pue M, et al. Mechanisms of in vivo DNA electrotransfer: Respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 2002;5:133.
63. Glander J, Norrild B, Persson MB, et al. Transfection of HeLa-cells with pEGFP plasmid by impedance power-assisted electropermeabilization. Biotechnol Bioeng 2005;92:267.